Serum matrix metalloproteilmse-2 level and its significance in patients with different stroke subtypes
Liying Gong, Xudong Pan
Abstract
Liying Gong, Xudong Pan
Abstract
Objective To investigate the change of serum matrix metalloproteinase-2 (MMP-2) level and its significance in patients with acute ischemic stroke of different subtypes. Methods Seventy-seven patients with acute ischemic stroke were classified into large-artery atherosclerosis (LAA) (n =29, 37.66% ), small artery occlusion (SAO, lacunar infarction) (n = 23,29. 87%), cardioembolism (CE) (n = 13,16.88%), stroke of undemonstrated etiology (SUE) (n = 7, 9.09% ), and stroke of other demonstrated etiology (SOE) (n = 5, 6.49% ) according to the TOAST criteria. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of serum MMP-2 in patients with acute ischemic stroke at 24 hours and 7 days, and they were compared with 42 controls, Results The eserum MMP-2 levels at 24 hours and 7 days of the onset of symptoms in the acute ischemic stroke group according to the TOAST criteriawere 189.55 ±24.79 and 307.46 ±84.16 ng/ml respectively, and they were all significantly higher than 159.76 ± 10.32 ng/ml in the control group (all P 〈0.05). Among all the TOAST subtypes, SOE and SUE were not analyzed because of the small numbers of cases; among other subtypes, the serum MMP-2 levels at 24 hours of the onset of symptoms in the LAA, SAO and CE groups were 218.60 ± 13.42,175.21±9.92, and 167.26 ±9.7 ng/ml respectively, and they were all significantly higher than those in the control group (all P 〈 0.05); at day 7 of the onset of symptoms they were 404.75 ±10.30,293.18±10.91, and 211.81±11.14 ng/ml respectively, and they were also significantly higher than those in the control group (all P 〈 0.05). Among those, the LAA group was increased significantly (P 〈 0.01). Conclusions The serum MMP-2 levels were increased in patients with acute cerebral infarction, The changes of the serum MMP-2 levels in each TOAST subtype group were different, The LAA group increased most significantly, which supported the different views of the etiology of cerebral infarction subtypes, The serum MMP-2 plays an important role in the process of cerebral infarction of the LAA type. Key words: stroke; etiology; matrix metalloproteinase 2
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the change of serum matrix metalloproteinase-2 (MMP-2) level and its significance in patients with acute ischemic stroke of different subtypes. Methods Seventy-seven patients with acute ischemic stroke were classified into large-artery atherosclerosis (LAA) (n =29, 37.66% ), small artery occlusion (SAO, lacunar infarction) (n = 23,29. 87%), cardioembolism (CE) (n = 13,16.88%), stroke of undemonstrated etiology (SUE) (n = 7, 9.09% ), and stroke of other demonstrated etiology (SOE) (n = 5, 6.49% ) according to the TOAST criteria. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of serum MMP-2 in patients with acute ischemic stroke at 24 hours and 7 days, and they were compared with 42 controls, Results The eserum MMP-2 levels at 24 hours and 7 days of the onset of symptoms in the acute ischemic stroke group according to the TOAST criteriawere 189.55 ±24.79 and 307.46 ±84.16 ng/ml respectively, and they were all significantly higher than 159.76 ± 10.32 ng/ml in the control group (all P 〈0.05). Among all the TOAST subtypes, SOE and SUE were not analyzed because of the small numbers of cases; among other subtypes, the serum MMP-2 levels at 24 hours of the onset of symptoms in the LAA, SAO and CE groups were 218.60 ± 13.42,175.21±9.92, and 167.26 ±9.7 ng/ml respectively, and they were all significantly higher than those in the control group (all P 〈 0.05); at day 7 of the onset of symptoms they were 404.75 ±10.30,293.18±10.91, and 211.81±11.14 ng/ml respectively, and they were also significantly higher than those in the control group (all P 〈 0.05). Among those, the LAA group was increased significantly (P 〈 0.01). Conclusions The serum MMP-2 levels were increased in patients with acute cerebral infarction, The changes of the serum MMP-2 levels in each TOAST subtype group were different, The LAA group increased most significantly, which supported the different views of the etiology of cerebral infarction subtypes, The serum MMP-2 plays an important role in the process of cerebral infarction of the LAA type. Key words: stroke; etiology; matrix metalloproteinase 2
Key concepts: Medicine, Etiology, Internal medicine, Stroke (engine), Gastroenterology, Acute stroke, Ischemic stroke, Clinical significance